Brief: HBM Holdings Enters Agreement With Umoja Biopharma
05/11/2025 15:46
Nov 5 (Reuters) - Hbm Holdings Ltd 2142.HK: ENTERS AGREEMENT WITH UMOJA BIOPHARMA ENTERS EVALUATION AND LICENSE AGREEMENT WITH UMOJA BIOPHARMA NONA BIOSCIENCES AND UMOJA TO CREATE IN VIVO CAR-T PRODUCTS NONA BIOSCIENCES ELIGIBLE FOR UPFRONT AND MILESTONE PAYMENTS Further company coverage: 2142.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study